Skip to main content
. 2023 Dec 29;11(12):e1121. doi: 10.1002/iid3.1121

Figure 4.

Figure 4

Illustrative depiction of biosensor construction deploying miRNA signature molecules corresponding to respective ADs using several biorecognition elements along with assistive nanomaterials for eliciting robust signal amplification to detect pathogenic miRNA indices. ADs, autoimmune diseases.